Original Research
Frequency and correlates of comorbid psychiatric illness in patients with heroin use disorder admitted to Stikland Opioid Detoxification Unit, South Africa
Submitted: 05 December 2013 | Published: 30 August 2014
About the author(s)
Lisa Dannatt, Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa, South AfricaKaren Jacqueline Cloete, Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa, South Africa
Martin Kidd, Centre for Statistical Consultation, Stellenbosch University, Cape Town, South Africa, South Africa
Lize Weich, Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa, South Africa
Full Text:
PDF (606KB)Abstract
Background. There is a lack of studies addressing the frequency and correlates of comorbidities among heroin users admitted for treatment in South Africa (SA). Objective. To assess the frequency and correlates of psychiatric comorbidity among patients with heroin use disorder admitted to the Opioid Detoxification Unit at Stikland Hospital in the Western Cape, SA.
Method. Participants (N=141) were assessed for psychiatric illness (Mini International Neuropsychiatric Interview), comorbid substance use disorders (World Health Organization’s Alcohol Smoking Substance Involvement Screening Tool), and legal and social problems (Maudsley Addiction Profile). Demographic, personal, psychiatric and substance-use history, in addition to mental state examination on admission, were collected from the case notes.
Results. The largest group of patients (n=56, 40%) had not been abstinent from heroin use since drug debut, and most had been arrested for drug-related activities (n=117, 83%) and had family conflicts related to use (n=135, 96%). Nicotine was the most common comorbid substance of dependence (n=137, 97%) and methamphetamine was the most common comorbid substance abused (n=73, 52%). The most common comorbid psychiatric illness was previous substance-induced psychosis (n=42, 30%) and current major depressive disorder (n=37, 26%). Current major depressive disorder was significantly associated with females (p=0.03), intravenous drug use (p=0.03), alcohol use (p=0.02), and a higher number of previous rehabilitation attempts (p=0.008).
Conclusion. Patients with heroin use disorders present with high rates of psychiatric comorbidities, which underscores the need for substance treatment services with the capacity to diagnose and manage these comorbidities.
Keywords
Metrics
Total abstract views: 4806Total article views: 1998
Crossref Citations
1. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study
Mpho Tlali, Andrew Scheibe, Yann Ruffieux, Morna Cornell, Anja E Wettstein, Matthias Egger, Mary-Ann Davies, Gary Maartens, Leigh F Johnson, Andreas D Haas
International Journal of Drug Policy vol: 109 first page: 103853 year: 2022
doi: 10.1016/j.drugpo.2022.103853
2. Feasibility, acceptability and preliminary efficacy of a cognitive behavior therapy text-message intervention among individuals with opioid use disorder in Kenya: a randomized feasibility trial
Sarah Kanana Kiburi, Edith Kamaru Kwobah, Saeeda Paruk, Bonginkosi Chiliza
BMC Digital Health vol: 1 issue: 1 year: 2023
doi: 10.1186/s44247-023-00014-3
3. Sex and gender differences in co-occurring substance use and depressive disorders: a systematic review
Parker Grant, Maryam Sorkhou, Julia Ryan, Tony P. George
The American Journal of Drug and Alcohol Abuse vol: 51 issue: 6 first page: 687 year: 2025
doi: 10.1080/00952990.2025.2577725
4. The burden of unlawful use of opioid and associated epidemiological characteristics in Africa: A scoping review
Hope Onohuean, Frasia Oosthuizen, Massimiliano Esposito
PLOS ONE vol: 20 issue: 3 first page: e0317036 year: 2025
doi: 10.1371/journal.pone.0317036
5. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa
Andrew Scheibe, Shaun Shelly, Tara Gerardy, Zara von Homeyer, Andrea Schneider, Kalvanya Padayachee, Shalon Balaguru Naidoo, Klaas Mtshweni, Ayanda Matau, Harry Hausler, Monique Marks
Addiction Science & Clinical Practice vol: 15 issue: 1 year: 2020
doi: 10.1186/s13722-020-00186-7
6. Southern African HIV Clinicians Society guidelines for harm reduction
Andrew Scheibe, Goodman Sibeko, Shaun Shelly, Theresa Rossouw, Vincent Zishiri, Willem D.F. Venter
Southern African Journal of HIV Medicine vol: 21 issue: 1 year: 2020
doi: 10.4102/sajhivmed.v21i1.1161